Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kymera Therapeutics (KYMR) Preferred Dividend Payments (2020)

Kymera Therapeutics (KYMR) has disclosed Preferred Dividend Payments for 1 consecutive years, with -$50000.0 as the latest value for Q2 2020.

  • On a quarterly basis, Preferred Dividend Payments changed N/A to -$50000.0 in Q2 2020 year-over-year; TTM through Dec 2020 was $9.0 million, a N/A change, with the full-year FY2020 number at $9.0 million, changed N/A from a year prior.
  • Preferred Dividend Payments was -$50000.0 for Q2 2020 at Kymera Therapeutics, down from $9.1 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $9.1 million in Q1 2020 to a low of -$50000.0 in Q2 2020.